WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

The Tracker / October 2025 / K251927

510(k) cleared

Zeta Navigation System (ZNS131-US)

Zeta Surgical, Inc. · Oct 10, 2025 · K251927 · In the directory

FDA cleared the Zeta Navigation System (ZNS131-US) from Zeta Surgical, Inc. on Oct 10, 2025 under K251927, a special 510(k). The device falls under product code SGE, Extracranial Positional System For A Transcranial Magnetic Stimulation System, regulated at 21 CFR 882.4560 as a Class 2 device. The review panel was Neurology.

FDA logged the submission as received on Jun 23, 2025. The decision came 109 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

Zeta Surgical, Inc. has 2 other decisions in the tracker over the last 12 months: K261471 (Zeta TMS Navigation System), K253663 (Zeta Navigation System).

Questions & Answers

What did FDA clear under K251927?

K251927 is the FDA 510(k) for Zeta Navigation System (ZNS131-US), submitted by Zeta Surgical, Inc.. FDA's decision date was Oct 10, 2025, under product code SGE (Extracranial Positional System For A Transcranial Magnetic Stimulation System).

Who makes the Zeta Navigation System (ZNS131-US)?

Zeta Surgical, Inc., based in Boston, MA, is the applicant of record for K251927. The company is listed in the MedDevice Startups directory.

How long did the K251927 review take?

FDA received the submission on Jun 23, 2025 and issued its decision on Oct 10, 2025, 109 days later.

← All decisions in October 2025

Sources

In the startup directory

Zeta Surgical

Surgical & Robotics · Boston, MA